- Home
- SSY vs CNSP Comparison
SSY vs CNSP Comparison
Compare SSY & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- CNSP
- Stock Information
- Founded
- SSY 1959
- CNSP 2017
- Country
- SSY United States
- CNSP United States
- Employees
- SSY N/A
- CNSP N/A
- Industry
- SSY Hospital/Nursing Management
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- CNSP Health Care
- Exchange
- SSY Nasdaq
- CNSP Nasdaq
- Market Cap
- SSY 5.3M
- CNSP 5.4M
- IPO Year
- SSY N/A
- CNSP 2019
- Fundamental
- Price
- SSY $0.77
- CNSP $0.11
- Analyst Decision
- SSY
- CNSP Strong Buy
- Analyst Count
- SSY 0
- CNSP 1
- Target Price
- SSY N/A
- CNSP $0.50
- AVG Volume (30 Days)
- SSY 19.2K
- CNSP 4.4M
- Earning Date
- SSY 02-11-2025
- CNSP 11-15-2024
- Dividend Yield
- SSY N/A
- CNSP N/A
- EPS Growth
- SSY N/A
- CNSP N/A
- EPS
- SSY N/A
- CNSP N/A
- Revenue
- SSY $31,808,000.00
- CNSP N/A
- Revenue This Year
- SSY N/A
- CNSP N/A
- Revenue Next Year
- SSY N/A
- CNSP N/A
- P/E Ratio
- SSY N/A
- CNSP N/A
- Revenue Growth
- SSY N/A
- CNSP N/A
- 52 Week Low
- SSY $0.53
- CNSP $0.10
- 52 Week High
- SSY $0.98
- CNSP $70.00
- Technical
- Relative Strength Index (RSI)
- SSY 48.56
- CNSP 45.26
- Support Level
- SSY $0.72
- CNSP $0.10
- Resistance Level
- SSY $0.77
- CNSP $0.12
- Average True Range (ATR)
- SSY 0.05
- CNSP 0.01
- MACD
- SSY -0.00
- CNSP 0.00
- Stochastic Oscillator
- SSY 57.70
- CNSP 41.38
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.